Top Markets
Coin of the day
UniPharma Co., Ltd. UniPharma Co., Ltd.

UniPharma Co., Ltd.

6621
Rank in Stocks #31502
UniPharma Co., Ltd. is a Taiwanese enterprise specializing in the distribution... UniPharma Co., Ltd. is a Taiwanese enterprise specializing in the distribution of pharmaceuticals, medical apparatus, and diagnostic kits. Its diagnostic portfolio encompasses various medical disciplines, including oncology, gynecology, orthopedics, neurology, anesthesiology, and cardiology. The company's offerings feature products such as Adept reduction solution, anesthetic injections (including bain, esmolol HCI, and naloxone), the Elisa DR-70 test for in-vitro tumor detection, and Fomeject antidote injections. Furthermore, UniPharma extends its services to include drug development, research and development, clinical studies, and marketing. Its client base includes major medical centers, regional hospitals, and local clinics. Founded in 1998, UniPharma is headquartered in Taipei, Taiwan.
Share Price
$0.36091897
Market Cap
$13.01M
Change (1 day)
-1.73%
Change (1 year)
-12.93%
Country
TW
Trade UniPharma Co., Ltd. (6621)

Category

Revenue for UniPharma Co., Ltd. (6621)
Revenue in Aug 2026 TTM: 0
According to UniPharma Co., Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for UniPharma Co., Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors